Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-driven Analysis

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT03793179
Protocol Number
C-372
Phase
III (Cancer Control)
Management Group
Oncology Network
Oncology Group
Lung Oncology Group
Disease Sites
Lung
Cancer Control
Y
Sponsor Protocol
EA5163
INSIGNA
Principal Investigator
Ioana Bonta
Scope
National
Participating Institutions
Atlanta Cancer Care - Atlanta
Atlanta Cancer Care - Cumming
Atlanta Cancer Care - Stockbridge
Georgia Cancer Specialists - Athens
Georgia Cancer Specialists - Blairsville
Georgia Cancer Specialists - Canton
Georgia Cancer Specialists - Cumming
Georgia Cancer Specialists - Decatur
Georgia Cancer Specialists - Macon
Georgia Cancer Specialists - Marietta
Georgia Cancer Specialists - Northside
Suburban Hematology Oncology Associates - Duluth
Suburban Hematology Oncology Associates - Lawrenceville

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or